View lab results AI Recommendations
Product Overview: GLP-1 S (10mg) is a research-grade peptide designed for exploration of its biological activity in metabolic and endocrinological studies
In the acute phase of AD, Th2-mediated immune reactions initiate the release of pro-inflammatory cytokines, further perpetuating the inflammatory cascade (45)
For most people, combining these medications does not significantly increase side effects
Safety Profile Across all six human trials and the extensive preclinical work, the safety picture is quite clean: No serious adverse events attributed to the compound No effect on IGF-1 No impairment of glucose tolerance or insulin sensitivity No genotoxic activity Most common side effects: mild injection site irritation, occasional headache or fatigue all transient This is genuinely one of the better-characterized peptides from a safety standpoint, largely because it actually went through a formal development process with proper clinical oversight
I test, was statistically significant in all subgroup analyses evaluating bowel preparation
